Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NovaBay Pharmaceuticals Inc. (NBY)

0.5925   -0.006 (-1.07%) 02-24 15:58
Open: 0.6 Pre. Close: 0.5989
High: 0.61 Low: 0.57
Volume: 320,455 Market Cap: 17M
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.611 - 0.614 0.614 - 0.617
Low: 0.563 - 0.566 0.566 - 0.569
Close: 0.585 - 0.59 0.59 - 0.594

Technical analysis

as of: 2020-02-24 4:45:43 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.74     One year: 0.83
Support: Support1: 0.50    Support2: 0.42
Resistance: Resistance1: 0.63    Resistance2: 0.71
Pivot: 0.56
Moving Average: MA(5): 0.57     MA(20): 0.57
MA(100): 0.60     MA(250): 0.86
MACD: MACD(12,26): -0.01     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 70.14     %D(3): 57.24
RSI: RSI(14): 53.43
52-week: High: 4.04  Low: 0.23  Change(%): -56.1
Average Vol(K): 3-Month: 29269  10-Days: 20188

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NBY has closed below upper band by 21.2%. Bollinger Bands are 14.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 24 Sep 2019 13:26:04 +0000
Health Care Sector Update for 09/24/2019: AIM, NBY, ZEAL, JNJ, PFE, ABT, MRK, AMGN

Thu, 28 Mar 2019 20:31:07 +0000
NovaBay Pharmaceuticals Swings to Loss in Q4 from Year Ago Amid Falling Revenue

Mon, 01 Apr 2019 17:48:15 +0000
NovaBay Pharmaceuticals Discloses $5 Mln Investment to Support Growth of Avenova

Tue, 30 Jul 2019 01:32:57 +0000
6 Top Gainers In Healthcare Sector (NBY, PIRS, VRCA...)

Fri, 19 Jul 2019 04:16:34 +0000
5 Top Losers In Healthcare Sector (LIFE, SENS, GHSI…)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27.90
Shares Float (M) 14.50
% Held by Insiders 25.54
% Held by Institutions 3.60
Shares Short (K) 627
Shares Short P. Month (K)

Stock Financials

EPS -0.457
Book Value (p.s.) 0.120
PEG Ratio
Profit Margin -96.71
Operating Margin -101.50
Return on Assets (ttm) -43.3
Return on Equity (ttm) -172.3
Qtrly Rev. Growth -48.6
Gross Profit (p.s.) 0.395
Sales Per Share
EBITDA (p.s.) -0.306
Qtrly Earnings Growth
Operating Cash Flow (M) -8.49
Levered Free Cash Flow (M) -4.59

Stock Valuations

P/E -1.30
P/E Growth Ratio -0.01
P/BV 4.94
P/S 1.31
P/CF -1.95

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-12-20
Last Split Ratio 0.04
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.